So based on the quarterly report today, I am hearing Novartis puts the blame squarely on Alcon. No raises and no bonuses in the works or 2017. Novartis of course cannot admit they are the ones that screwed us up, and now punish us for what they did.
We won't make our target, but be told that everything is still on the up and up. Meanwhile Novartis will blame their earnings on Alcon at the next shareholders' meeting. Rinse and repeat every quarter.